Skip to content

Remote Ischemic Preconditioning in Cardiac Surgery

Implications of Remote Ischemic Preconditioning on Liver Function in Adults Undergoing Cardiac Surgery: Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04647370
Enrollment
90
Registered
2020-11-30
Start date
2021-04-01
Completion date
2022-03-31
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia Reperfusion Injury

Brief summary

Aim of the work : Evaluation of the role of Remote Ischemic Preconditioning (RIP) on liver function in patients undergoing on-pump cardiac surgery.

Interventions

PROCEDUREremote ischemic preconditioning

3 cycles of 5-minutes inflation of a blood pressure cuff to 200mmHg (or at least to a pressure 50mm Hg higher than the systolic arterial pressure) to one upper arm, followed by5-minutes reperfusion with the cuff deflated

3cycles of upper limb pseudo ischemia (low pressure, 5-minutes blood pressure cuff inflation to a pressure of 20 mm Hg and 5-minutes cuff deflation).

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Being candidate for on-pump cardiac surgery. 2. Willing to participate in the study 3. Ages eligible for the study: 18 to 70 years. 4. Gender eligible for the study : both

Exclusion criteria

1. Patient refusal. 2. Known cause of possible liver function disturbances that includes right heart failure, acute inflammation of gallbladder or any other complication of gallstone disease. 3. Active viral and non viral hepatitis. 4. Pregnant women. 5. History of peripheral nerve disease or peripheral vascular disease of the extremities

Design outcomes

Primary

MeasureTime frameDescription
liver function test3 postoperative daysDirect Bilirubin

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026